Belimumab in Autoimmune Hepatitis
Abroad (travel likely)RecruitingPHASE2
Conditions
Autoimmune Hepatitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Calgary, Calgary, Alberta, Canada
G.I Research Institute, Vancouver, British Columbia, Canada
McMaster University, Hamilton, Ontario, Canada
London Health Sciences Centre, London, Ontario, Canada
Toronto General Hospital, Toronto, Ontario, Canada
Study leads
Gideon Hirschfield, MB BChir, PhD
Principal Investigator
University Health Network, Toronto